Merck Advances EyeBio’s Restoret for Diabetic Macular Edema Treatment
In a recent acquisition worth $1.3 billion, Merck & Co. has launched a late-stage study for Restoret, their key...
late-stage study
Roche’s Xolair Receives FDA Priority Review for Allergy Treatment
Roche Holding's Xolair antibody has received priority review from the FDA after a successful late-stage study. Xolair could become...
Novartis Drug Shows Promise in Kidney Disease Study
Novartis's experimental drug iptacopan has successfully met its primary goal in a late-stage clinical trial for the treatment of...
Merck Ends Phase 3 Keytruda-Lynparza Lung Cancer Study
In a major setback for Merck & Co., the pharmaceutical company is ending a late-stage study of the combination...
Promising Results for Roche’s Inavolisib in Breast Cancer Study
Roche Holding has announced promising results from a late-stage study of its investigational breast cancer treatment, inavolisib. The phase...